Cargando…
Gastric polyps' regression after potassium‐competitive acid blocker cessation
Esophagogastroduodenoscopic examination shows a large, reddish polyp in the gastric cardia. The polyp decreased in size at 10 months and 22 months after cessation of vonoprazan.[Image: see text]
Autores principales: | Iwamuro, Masaya, Shiraha, Hidenori, Okada, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444017/ https://www.ncbi.nlm.nih.gov/pubmed/36093226 http://dx.doi.org/10.1002/jgf2.552 |
Ejemplares similares
-
Laminin 511-E8 Fragment Offers Superior Adhesion Properties for Gastric Cancer Cells Compared with Full-Length Laminin 511
por: Iwamuro, Masaya, et al.
Publicado: (2022) -
Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
por: Masaoka, Tatsuhiro, et al.
Publicado: (2018) -
A Huge Liver Cyst Manifesting Dyspnea and Edema
por: Nagao, Satoko, et al.
Publicado: (2019) -
Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
por: Cho, Yu Kyung, et al.
Publicado: (2020) -
Diffuse redness in linked color imaging is useful for diagnosing current Helicobacter pylori infection in the stomach
por: Iwamuro, Masaya, et al.
Publicado: (2018)